105 related articles for article (PubMed ID: 10579750)
1. Efficacy of angiotensin II antagonists in hypertension.
Spence JD
Can J Cardiol; 1999 Nov; 15 Suppl F():33F-5F. PubMed ID: 10579750
[TBL] [Abstract][Full Text] [Related]
2. Olmesartan compared with other angiotensin II receptor antagonists: head-to-head trials.
Stumpe KO
Clin Ther; 2004; 26 Suppl A():A33-7. PubMed ID: 15291378
[TBL] [Abstract][Full Text] [Related]
3. [Angiotensin I receptor antagonist losartan. Part II. Effects in arterial hypertension and diabetic nephropathy].
Sidorenko BA; Preobrazhenskiĭ DV; Stetsenko TM; Tarykina EV; Tsurko VV
Kardiologiia; 2003; 43(2):88-95. PubMed ID: 12891278
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II antagonists for hypertension: are there differences in efficacy?
Conlin PR; Spence JD; Williams B; Ribeiro AB; Saito I; Benedict C; Bunt AM
Am J Hypertens; 2000 Apr; 13(4 Pt 1):418-26. PubMed ID: 10821345
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data].
Paoletti V; Di Veroli C; Pugliese M; Cammarella I; Cavina G; Turchetti P; Mammarella A
Clin Ter; 2002; 153(1):61-4. PubMed ID: 11963637
[TBL] [Abstract][Full Text] [Related]
6. Cardiology patient page. Angiotensin receptor blockers.
Terra SG
Circulation; 2003 Jun; 107(24):e215-6. PubMed ID: 12821593
[No Abstract] [Full Text] [Related]
7. Angiotensin II receptor antagonists in the treatment of hypertension.
Kaplan NM
Am Fam Physician; 1999 Sep; 60(4):1185-90. PubMed ID: 10507747
[TBL] [Abstract][Full Text] [Related]
8. [Fast-acting sartan. High blood pressure therapy without long waiting time].
MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
[No Abstract] [Full Text] [Related]
9. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Weisser B; Gerwe M; Braun M; Funken C
Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
[TBL] [Abstract][Full Text] [Related]
10. [Lowering blood pressure with sartans. Are there differences?].
MMW Fortschr Med; 2002 Nov; 144(47):63. PubMed ID: 12532530
[No Abstract] [Full Text] [Related]
11. A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
Hedner T; Oparil S; Rasmussen K; Rapelli A; Gatlin M; Kobi P; Sullivan J; Oddou-Stock P
Am J Hypertens; 1999 Apr; 12(4 Pt 1):414-7. PubMed ID: 10232502
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
13. Valsartan treatment of hypertension--does VALUE add value?
Lindholm LH
Lancet; 2004 Jun; 363(9426):2010-1. PubMed ID: 15207946
[No Abstract] [Full Text] [Related]
14. [Irbesartan: a new possibility in the treatment of hypertension].
Rapi J
Orv Hetil; 2002 May; 143(21):1187-92. PubMed ID: 12073539
[TBL] [Abstract][Full Text] [Related]
15. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
16. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
Uzu T; Sakaguchi M; Yokomaku Y; Kume S; Kanasaki M; Isshiki K; Araki SI; Sugiomoto T; Koya D; Haneda M; Kashiwagi A
Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
[TBL] [Abstract][Full Text] [Related]
18. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
Weisser B; Vetter H; Mengden T
Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
[TBL] [Abstract][Full Text] [Related]
19. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
20. The relationships between dose and antihypertensive effect of four AT1-receptor blockers. Differences in potency and efficacy.
Elmfeldt D; Olofsson B; Meredith P
Blood Press; 2002; 11(5):293-301. PubMed ID: 12458652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
